Historically, drug pricing reforms have operated within the silos of Medicare reimbursement, insurance subsidies, and plan-level negotiation. TrumpRx is now challenging this intermediary structure, ...

As states cut Medicaid coverage for GLP-1 drugs, access to obesity treatment is increasingly tied to income—raising questions for both Medicaid and Medicare.

A retired Asheville doctor will pay back half a million dollars after facing allegations of Medicare fraud, records show.

Healthcare experts answer the most common questions about TrumpRx, plus who this new government portal is best for.

Confidently Navigating Today's Job market: Smart Strategies for Experienced Workers Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental A new study suggests the answer may ...

In the $1.2 trillion budget package signed Tuesday, a little-known healthcare provision was reauthorized that will allow ...

With the spike in Affordable Care Act health insurance costs, around 4·8 million people could lose coverage. Susan Jaffe reports from Washington, DC.

MyCare Ohio is a Medicare-Medicaid managed care program for Ohioans who are eligible for both. The plan is new as of Jan. 1, 2026, and integrates benefits from both programs into a single health plan ...

The 2028 negotiation cycle marks another major inflection point in the implementation of the Medicare Drug Price Negotiation Program—its first year incorporating Part B drugs and its first opportunity ...

The government proposed boosting payments to Medicare Advantage plans by 0.09% in 2027, below what they and their investors expected. What would it mean for enrollees?

When you have a rare disease, managing doctor's appointments, prescriptions and care plans is difficult enough — figuring out what Medicare will (and won't) cover often adds another layer of stress.

Provider groups are calling on CMS to adopt new rules that hold MA plans more accountable for “egregious” denials while also ...